AEON Biopharma (AEON) Change in Cash (2021 - 2025)
AEON Biopharma (AEON) posted Change in Cash of -$2.9 million for Q4 2025, down 16.28% sequentially from -$2.5 million in Q3 2025, and down 457.44% YoY from $817193.8 in Q4 2024.
AEON Biopharma (AEON) Change in Cash (2021 - 2025) Analysis & Trends
AEON Biopharma has reported Change in Cash for 5 years, with the latest figure at -$2.9 million in Q4 2025.
- Quarterly Change in Cash fell 457.44% year-over-year to -$2.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (up 117.3% YoY) and the FY2025 annual result came in at $3.0 million, up 158.17% from the prior year.
- Change in Cash fell to -$2.9 million in Q4 2025 per AEON's latest filing, from -$2.5 million in the prior quarter.
- Over five years, Change in Cash peaked at $17.6 million in Q3 2022 and troughed at -$15.1 million in Q3 2023.
- A 5-year average of -$838269.9 and a median of -$452644.0 in 2021 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 5498.66% in 2022, down 7397.23% in 2022.
- Over 5 years, Change in Cash stood at -$166128.0 in 2021, then tumbled by 7397.23% to -$12.5 million in 2022, then dropped by 20.92% to -$15.1 million in 2023, then jumped by 96.52% to -$524000.0 in 2024, then sank by 457.44% to -$2.9 million in 2025.
- According to Business Quant data, Change in Cash over the past three periods registered -$2.9 million, -$2.5 million, and -$2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | AEON Biopharma | 9.71 Mn | 6.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.92 Mn |
| Sep 30, 2025 | -2.51 Mn |
| Jun 30, 2025 | -2.01 Mn |
| Mar 31, 2025 | 10.43 Mn |
| Dec 31, 2024 | -524,000.00 |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | -3.60 Mn |
| Sep 30, 2023 | -15.06 Mn |
| Mar 31, 2023 | -5.06 Mn |
| Dec 31, 2022 | -12.46 Mn |
| Sep 30, 2022 | 17.56 Mn |
| Jun 30, 2022 | -158,485.00 |
| Mar 31, 2022 | -331,169.00 |
| Dec 31, 2021 | -166,128.00 |
| Sep 30, 2021 | -325,315.00 |
| Jun 30, 2021 | -452,644.00 |
| Mar 31, 2021 | 1.44 Mn |